Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Viral Vector Production (Research-Use) Market Growth From $2.04 Billion In 2026 To $3.56 Billion By 2030 At A CAGR Of 14.9%
The market for viral vector production intended for research applications has experienced notable expansion in recent times. Projected to rise from $1.77 billion in 2025 to $2.04 billion in 2026, this reflects a compound annual growth rate (CAGR) of 15.2%. This historical growth has been driven by heightened funding for gene therapy research, the broadening of academic and translational research initiatives, the accessibility of sophisticated cell culture methods, an increased application of viral vectors in oncology investigations, and a surge in contract research operations.
The market size for viral vector production (research-use) is anticipated to expand rapidly over the coming years. By 2030, it is projected to reach $3.56 billion, driven by a compound annual growth rate (CAGR) of 14.9%. This growth in the forecast period is largely fueled by a rising need for advanced gene delivery tools, greater adoption of automation within research labs, expanded research into CRISPR and gene editing, increased partnerships between academic institutions and biopharmaceutical companies, and a heightened emphasis on reproducibility and standardization. Key trends shaping the forecast period include a growing preference for scalable manufacturing platforms for viral vectors, an increased demand for high-purity research-grade vectors, wider use of suspension cell culture systems, expansion of automated upstream and downstream processes, and a stronger focus on vector characterization and quality assurance.
Download A Free Sample Report For Comprehensive Market Insights:
Viral Vector Production (Research-Use) Market Industry Drivers: What Is Driving Revenue Growth?
The anticipated expansion of the viral vector production market for research purposes is being driven by the increasing prevalence of genetic disorders. These disorders arise from abnormalities in an individual’s deoxyribonucleic acid, which may be inherited from either parent or emerge from new genetic mutations. Their rising frequency is linked to advanced parental age, which heightens the risk of passing genetic mutations to children. This growing incidence fuels demand for sophisticated gene delivery tools essential for studying disease mechanisms and creating potential therapies, thereby supporting market growth. For example, in November 2024, the Centers for Disease Control and Prevention (CDC), a US governmental public health body, reported that Trisomy 21 (Down syndrome) affects roughly 1 in 643 births, leading to about 5,713 new cases each year, while Trisomy 18 occurs in around 1 in 3,336 births, or approximately 1,101 annual cases. Consequently, the rising frequency of genetic disorders is poised to advance the viral vector production (research-use) market.
Viral Vector Production (Research-Use) Market Segmentation And Category Breakdown
The viral vector production (research-use) market covered in this report is segmented –
1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types
2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods
3) By Workflow: Upstream Processing, Downstream Processing
4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications
5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes
Subsegments:
1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus
2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus
3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus
4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus
5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors
Viral Vector Production (Research-Use) Market Growth Trends: What Is Influencing The Future Outlook?
Key players in the viral vector production industry are increasingly investing in the creation of innovative tools, particularly customized cell culture media, aimed at enhancing transfection efficiency, maximizing viral vector output, and maintaining reliable quality for research purposes. Cell culture media consist of nutrient-dense formulations that facilitate the cultivation and preservation of cells outside their native environment, incorporating critical components such as amino acids, vitamins, and growth factors tailored to specific cell varieties and uses. A notable example occurred in January 2023, when FUJIFILM Irvine Scientific, a life sciences company headquartered in the United States, unveiled BalanCD HEK293 Viral Feed, the first chemically defined nutrient supplement specifically engineered for HEK293 suspension cultures utilized in AAV viral vector production. With this product, the company intends to achieve substantial increases in adeno-associated virus (AAV) yields, demonstrating up to a 67% improvement in viral packaging efficiency compared to basal media. This feed is designed to support scalable gene therapy and biotechnological operations, delivering consistent performance across different formats and ensuring compatibility with a variety of media systems.
Viral Vector Production (Research-Use) Market Competitive Analysis Of Major Industry Participants
Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.
Access The Complete Viral Vector Production (Research-Use) Market Report:
Viral Vector Production (Research-Use) Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model